Compile Data Set for Download or QSAR
maximum 50k data
Found 283 with Last Name = 'baskaran' and Initial = 's'
TargetCaspase-1(Homo sapiens (Human))
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50176493((S)-3-((S)-2-((S)-3-methyl-2-(4-(quinoxalin-2-ylam...)
Affinity DataKi:  4nMAssay Description:Inhibitory activity against human Caspase 1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCaspase-1(Homo sapiens (Human))
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50176494((3S)-3-(6-(3-methyl-4-(quinoxalin-2-ylamino)benzam...)
Affinity DataKi:  4nMAssay Description:Inhibitory activity against human Caspase 1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCaspase-1(Homo sapiens (Human))
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50176495((3S)-4-oxo-3-(2-phenyl-6-(4-(quinoxalin-2-ylamino)...)
Affinity DataKi:  5nMAssay Description:Inhibitory activity against human Caspase 1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCaspase-1(Homo sapiens (Human))
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50176496((3S)-3-(6-(4-(6-methylquinoxalin-2-ylamino)benzami...)
Affinity DataKi:  5nMAssay Description:Inhibitory activity against human Caspase 1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCaspase-1(Homo sapiens (Human))
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50176510((S)-4-oxo-3-(2-((4-(quinoxalin-2-ylamino)benzamido...)
Affinity DataKi:  5nMAssay Description:Inhibitory activity against human Caspase 1More data for this Ligand-Target Pair
TargetCaspase-1(Homo sapiens (Human))
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50176500((3S)-4-oxo-3-(6-(4-(quinoxalin-2-ylamino)benzamido...)
Affinity DataKi:  7nMAssay Description:Inhibitory activity against human Caspase 1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCaspase-1(Homo sapiens (Human))
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50176509((3S)-3-(2-(2-fluorophenyl)-6-(4-(quinoxalin-2-ylam...)
Affinity DataKi:  8nMAssay Description:Inhibitory activity against human Caspase 1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCaspase-1(Homo sapiens (Human))
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50176519((S)-3-[(S)-2-((S)-2-Benzyloxycarbonylamino-3-methy...)
Affinity DataKi:  8nMAssay Description:Inhibitory activity against human Caspase 1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCaspase-1(Homo sapiens (Human))
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50176505((3S)-3-(2-ethyl-6-(4-(quinoxalin-2-ylamino)benzami...)
Affinity DataKi:  16nMAssay Description:Inhibitory activity against human Caspase 1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCaspase-1(Homo sapiens (Human))
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50176508((S)-4-oxo-3-(2-((4-(quinoxalin-2-ylamino)benzamido...)
Affinity DataKi:  35nMAssay Description:Inhibitory activity against human Caspase 1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCaspase-1(Homo sapiens (Human))
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50176502((3S)-4-oxo-3-(6-(4-(quinoxalin-2-yloxy)benzamido)-...)
Affinity DataKi:  43nMAssay Description:Inhibitory activity against human Caspase 1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCaspase-1(Homo sapiens (Human))
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50176504((3S)-3-(6-(4-(6-chloropyrazin-2-ylamino)benzamido)...)
Affinity DataKi:  54nMAssay Description:Inhibitory activity against human Caspase 1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCaspase-1(Homo sapiens (Human))
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50176497((S)-4-oxo-3-(4-((4-(quinoxalin-2-ylamino)benzamido...)
Affinity DataKi:  100nMAssay Description:Inhibitory activity against human Caspase 1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCaspase-1(Homo sapiens (Human))
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50176513((3S)-4-oxo-3-(6-(4-(pyrazin-2-ylamino)benzamido)-2...)
Affinity DataKi:  100nMAssay Description:Inhibitory activity against human Caspase 1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCaspase-1(Homo sapiens (Human))
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50176512((S)-4-oxo-3-(2-((4-(quinoxalin-2-ylamino)benzamido...)
Affinity DataKi:  120nMAssay Description:Inhibitory activity against human Caspase 1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCaspase-1(Homo sapiens (Human))
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50176498((S)-4-oxo-3-(2-(5-((4-(quinoxalin-2-ylamino)benzam...)
Affinity DataKi:  120nMAssay Description:Inhibitory activity against human Caspase 1More data for this Ligand-Target Pair
TargetCaspase-1(Homo sapiens (Human))
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50176517(CHEMBL159822 | Z-YVAD-CHO)
Affinity DataKi:  180nMAssay Description:Inhibitory activity against human Caspase 1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCaspase-1(Homo sapiens (Human))
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50176515((S)-4-oxo-3-(6-(4-(quinoxalin-2-ylamino)benzamido)...)
Affinity DataKi:  190nMAssay Description:Inhibitory activity against human Caspase 1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCaspase-1(Homo sapiens (Human))
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50176511((S)-4-oxo-3-(3-(4-(quinoxalin-2-ylamino)benzamido)...)
Affinity DataKi:  260nMAssay Description:Inhibitory activity against human Caspase 1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCaspase-1(Homo sapiens (Human))
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50176506((S)-3-(6-(3-methyl-4-(quinoxalin-2-ylamino)benzami...)
Affinity DataKi:  320nMAssay Description:Inhibitory activity against human Caspase 1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCaspase-1(Homo sapiens (Human))
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50176507((S)-4-oxo-3-(2-((4-(quinoxalin-2-ylamino)benzamido...)
Affinity DataKi:  1.00E+3nMAssay Description:Inhibitory activity against human Caspase 1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCaspase-1(Homo sapiens (Human))
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50176503((S)-4-oxo-3-((1r,4S)-4-((4-(quinoxalin-2-ylamino)b...)
Affinity DataKi:  1.95E+3nMAssay Description:Inhibitory activity against human Caspase 1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCaspase-1(Homo sapiens (Human))
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50176514((S)-4-oxo-3-(2-((4-(quinoxalin-2-ylamino)benzamido...)
Affinity DataKi:  2.10E+3nMAssay Description:Inhibitory activity against human Caspase 1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCaspase-1(Homo sapiens (Human))
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50176516((S)-4-oxo-3-(7-oxo-7-(4-(quinoxalin-2-ylamino)phen...)
Affinity DataKi:  2.10E+3nMAssay Description:Inhibitory activity against human Caspase 1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCaspase-1(Homo sapiens (Human))
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50176501((S)-4-oxo-3-(6-(4-(quinoxalin-2-yloxy)benzamido)he...)
Affinity DataKi:  2.40E+3nMAssay Description:Inhibitory activity against human Caspase 1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCaspase-1(Homo sapiens (Human))
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50176520((S)-4-oxo-3-(7-(4-(quinoxalin-2-ylamino)benzamido)...)
Affinity DataKi:  2.60E+3nMAssay Description:Inhibitory activity against human Caspase 1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCaspase-1(Homo sapiens (Human))
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50176499((S)-4-oxo-3-(5-(4-(quinoxalin-2-ylamino)benzamido)...)
Affinity DataKi:  2.80E+3nMAssay Description:Inhibitory activity against human Caspase 1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCaspase-1(Homo sapiens (Human))
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50176518((S)-4-oxo-3-(4-(4-(quinoxalin-2-ylamino)benzamido)...)
Affinity DataKi:  5.20E+3nMAssay Description:Inhibitory activity against human Caspase 1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCaspase-1(Homo sapiens (Human))
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50176492((S)-4-oxo-3-(6-(4-(pyrazin-2-ylamino)benzamido)hex...)
Affinity DataKi:  3.70E+4nMAssay Description:Inhibitory activity against human Caspase 1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAurora kinase A(Mus musculus (mouse))
Sunesis Pharmaceuticals

LigandPNGBDBM26333(1-[3-(pyrrolidin-1-ylmethyl)-5-(trifluoromethyl)ph...)
Affinity DataIC50:  4nMpH: 7.2 T: 2°CAssay Description:Compounds were diluted into assay buffer containing Aurora kinase and FAM-PKAtide. The kinase reaction was initiated by adding ATP in assay buffer. T...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAurora kinase B(Homo sapiens (Human))
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50310621(CHEMBL1079538 | N-(4-(6-(trifluoromethyl)-3H-imida...)
Affinity DataIC50:  5nMAssay Description:Inhibition of Aurora B after 60 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAurora kinase B(Homo sapiens (Human))
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50310608(CHEMBL1077729 | N-(4-(5-(trifluoromethyl)-1H-benzo...)
Affinity DataIC50:  6nMAssay Description:Inhibition of Aurora B after 60 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAurora kinase B(Homo sapiens (Human))
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50310607(CHEMBL1078060 | N-(4-(5-chloro-1H-benzo[d]imidazol...)
Affinity DataIC50:  8nMAssay Description:Inhibition of Aurora B after 60 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAurora kinase A(Mus musculus (mouse))
Sunesis Pharmaceuticals

LigandPNGBDBM26326(1-(3-chlorophenyl)-3-[5-(2-{thieno[3,2-d]pyrimidin...)
Affinity DataIC50:  9nMpH: 7.2 T: 2°CAssay Description:Compounds were diluted into assay buffer containing Aurora kinase and FAM-PKAtide. The kinase reaction was initiated by adding ATP in assay buffer. T...More data for this Ligand-Target Pair
TargetAurora kinase A(Mus musculus (mouse))
Sunesis Pharmaceuticals

LigandPNGBDBM26322(1-(3-methylphenyl)-3-[5-(2-{thieno[3,2-d]pyrimidin...)
Affinity DataIC50:  9nMpH: 7.2 T: 2°CAssay Description:Compounds were diluted into assay buffer containing Aurora kinase and FAM-PKAtide. The kinase reaction was initiated by adding ATP in assay buffer. T...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAurora kinase A(Homo sapiens (Human))
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM26326(1-(3-chlorophenyl)-3-[5-(2-{thieno[3,2-d]pyrimidin...)
Affinity DataIC50:  9nMAssay Description:Inhibition of Aurora A after 60 minsMore data for this Ligand-Target Pair
TargetAurora kinase B(Homo sapiens (Human))
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50310620(CHEMBL1079713 | N-(4-(6-chloro-3H-imidazo[4,5-b]py...)
Affinity DataIC50:  10nMAssay Description:Inhibition of Aurora B after 60 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAurora kinase B(Homo sapiens (Human))
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50310614(CHEMBL1078906 | N-(4-(1H-benzo[d]imidazol-2-ylamin...)
Affinity DataIC50:  10nMAssay Description:Inhibition of Aurora B after 60 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAurora kinase A(Mus musculus (mouse))
Sunesis Pharmaceuticals

LigandPNGBDBM26330(1-(3-chloro-4-fluorophenyl)-3-[5-(2-{thieno[3,2-d]...)
Affinity DataIC50:  11nMpH: 7.2 T: 2°CAssay Description:Compounds were diluted into assay buffer containing Aurora kinase and FAM-PKAtide. The kinase reaction was initiated by adding ATP in assay buffer. T...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAurora kinase B(Homo sapiens (Human))
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM26329(1-(3,4-dichlorophenyl)-3-[5-(2-{thieno[3,2-d]pyrim...)
Affinity DataIC50:  13nMAssay Description:Compounds were diluted into assay buffer containing Aurora kinase and FAM-PKAtide. The kinase reaction was initiated by adding ATP in assay buffer. T...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAurora kinase B(Homo sapiens (Human))
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM26315(3-[5-(2-{thieno[3,2-d]pyrimidin-4-ylamino}ethyl)-1...)
Affinity DataIC50:  14nMAssay Description:Inhibition of Aurora B after 60 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAurora kinase B(Homo sapiens (Human))
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM26315(3-[5-(2-{thieno[3,2-d]pyrimidin-4-ylamino}ethyl)-1...)
Affinity DataIC50:  14nMAssay Description:Compounds were diluted into assay buffer containing Aurora kinase and FAM-PKAtide. The kinase reaction was initiated by adding ATP in assay buffer. T...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAurora kinase A(Homo sapiens (Human))
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50310621(CHEMBL1079538 | N-(4-(6-(trifluoromethyl)-3H-imida...)
Affinity DataIC50:  17nMAssay Description:Inhibition of Aurora A after 60 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAurora kinase B(Homo sapiens (Human))
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM26325(1-(3-fluorophenyl)-3-[5-(2-{thieno[3,2-d]pyrimidin...)
Affinity DataIC50:  18nMAssay Description:Compounds were diluted into assay buffer containing Aurora kinase and FAM-PKAtide. The kinase reaction was initiated by adding ATP in assay buffer. T...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAurora kinase B(Homo sapiens (Human))
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM26331(1-1H-indol-7-yl-3-[5-(2-{thieno[3,2-d]pyrimidin-4-...)
Affinity DataIC50:  19nMAssay Description:Compounds were diluted into assay buffer containing Aurora kinase and FAM-PKAtide. The kinase reaction was initiated by adding ATP in assay buffer. T...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAurora kinase A(Homo sapiens (Human))
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50310620(CHEMBL1079713 | N-(4-(6-chloro-3H-imidazo[4,5-b]py...)
Affinity DataIC50:  20nMAssay Description:Inhibition of Aurora A after 60 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAurora kinase B(Homo sapiens (Human))
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50310622(CHEMBL1078061 | N-(3-fluoro-4-(5-(trifluoromethyl)...)
Affinity DataIC50:  21nMAssay Description:Inhibition of Aurora B after 60 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAurora kinase A(Homo sapiens (Human))
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM26315(3-[5-(2-{thieno[3,2-d]pyrimidin-4-ylamino}ethyl)-1...)
Affinity DataIC50:  22nMAssay Description:Inhibition of Aurora A after 60 minsMore data for this Ligand-Target Pair
TargetAurora kinase B(Homo sapiens (Human))
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM26333(1-[3-(pyrrolidin-1-ylmethyl)-5-(trifluoromethyl)ph...)
Affinity DataIC50:  22nMAssay Description:Compounds were diluted into assay buffer containing Aurora kinase and FAM-PKAtide. The kinase reaction was initiated by adding ATP in assay buffer. T...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAurora kinase A(Mus musculus (mouse))
Sunesis Pharmaceuticals

LigandPNGBDBM26315(3-[5-(2-{thieno[3,2-d]pyrimidin-4-ylamino}ethyl)-1...)
Affinity DataIC50:  22nMpH: 7.2 T: 2°CAssay Description:Compounds were diluted into assay buffer containing Aurora kinase and FAM-PKAtide. The kinase reaction was initiated by adding ATP in assay buffer. T...More data for this Ligand-Target Pair
Displayed 1 to 50 (of 283 total ) | Next | Last >>
Jump to: